Zymex Pharmaceuticals

University of Georgia, 2000 - $17,000

This E-Team developed proof of concept for a drug discovery technology to identify promising protease inhibitors for application in a wide variety of diseases. The project was based on work done by a graduate student and a business plan developed for a competition at UGA in which it took first prize. The team, consisting of the grad student and a group of MBA and law students, assembled a group of technical and business advisors with the intention of launching a startup to commercialize the drug discovery process. The process, called Zymaccel, has several advantages over traditional approaches that could result in improved cost efficiency and better performing drugs with fewer side effects. Tests of the first compound identified with this system were promising. The E-Team proved the process by identifying three additional compounds, and continued to pursue commercial development of the process and product.